Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Economic burden assessment for the management of asthma patients at Mexico’s National Institute for Respiratory Diseases

Background. In Mexico, asthma is one of the top twenty causes of disease with 254,713 new cases reported in 2019. According to Phase 3 of the International Study of Asthma and Allergies in Childhood, the prevalence of asthma ranged from 5 to 14% in 6 Mexican cities with varied geographic conditions...

Full description

Bibliographic Details
Main Authors: Maria del Carmen Cano Salas, José Luis Miguel Reyes, Karen Sánchez Trejo, Erika del Carmen López Estrada, Jorge Salas Hernández, Monserrat Evelia Arroyo Rojas, Mauricio Castañeda Valdivia, Monserrat Escobar Preciado, Silvia Guzmán Vázquez, Sergio Ricardo García-García, Herman Soto Molina
Format: Article
Language:English
Published: Colegio Mexicano de Inmunología Clínica y Alergia, A.C. 2024-04-01
Series:Revista Alergia México
Subjects:
Adverse reaction to the drug
Online Access:https://revistaalergia.mx/ojs/index.php/ram/article/view/1279

Similar Items

Similar Items